Option Care Health reported weaker-than-expected Q1 2026 results with revenue of $1.35 billion, up only 1.3% year over year, and net income down 3%. The company lowered its full-year 2026 revenue guidance from $5.8-$6.0 billion to $5.675-$5.775 billion, citing lower patient retention and therapy mix issues. Following this, shares dropped about 24%, prompting a law firm investigation into possible securities law violations by the company or its management. No lawsuit has been filed yet, but investors are advised to stay informed as the investigation continues.
Novee has introduced Agentic Fix, an enhancement to its AI penetration testing platform that automates the transition from identifying security vulnerabilities to deploying fixes. This tool generates detailed remediation guidance based on validated e...
The American Society for Dermatologic Surgery (ASDS) has revamped its DermSurgery Digest Podcast to include a new video format with four monthly episodes divided into two categories: "Cosmetic and General Dermatology" and "Surgical Oncology and Recon...
Meritage Homes continues its 13-year partnership with Operation Homefront by donating a mortgage-free home to a military family in Gulfport, Mississippi. This marks the 22nd home Meritage has provided to veterans, supporting their transition to civil...
Esperion Therapeutics presented new data at the 2026 European Atherosclerosis Society Congress showing bempedoic acid effectively lowers LDL cholesterol in children aged 6-17 with familial hypercholesterolemia and is well tolerated. A secondary analy...
Rhythm Pharmaceuticals announced that its CEO and CFO will participate in fireside chats at the Jefferies Global Healthcare Conference on June 4 and the Goldman Sachs Global Healthcare Conference on June 8, 2026. These events will be webcast and acce...
